HCPCS code Q5134 — Inj, tyruko, 1 mg. Status: Active. Effective Apr 1, 2024. Source: CMS HCPCS Level II.

Q5134

Active

Inj, tyruko, 1 mg

Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Apr 1, 2024
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 0921

MUE — Medically Unlikely Edits

Maximum units of Q5134 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 300
Outpatient Hospital 300
Practitioner Services 300

Source: CMS Medicare NCCI Medically Unlikely Edits

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q2
    Inj, tyruko, 1 mg